Cross Country Healthcare (NASDAQ:CCRN) Price Target Cut to $16.50 by Analysts at UBS Group

Cross Country Healthcare (NASDAQ:CCRN) had its price target lowered by UBS Group from $18.61 to $16.50 in a research note published on Tuesday,Benzinga reports. The firm currently has a neutral rating on the business services provider’s stock.

A number of other equities analysts have also recently weighed in on the stock. Barrington Research reaffirmed a “market perform” rating and set a $18.61 price objective on shares of Cross Country Healthcare in a research report on Friday, March 14th. JMP Securities restated a “market perform” rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. Finally, StockNews.com started coverage on Cross Country Healthcare in a research note on Wednesday, May 7th. They issued a “hold” rating for the company. Seven investment analysts have rated the stock with a hold rating, According to MarketBeat, Cross Country Healthcare currently has an average rating of “Hold” and an average target price of $17.93.

Cross Country Healthcare Stock Down 0.3%

NASDAQ:CCRN opened at $13.95 on Tuesday. Cross Country Healthcare has a 52 week low of $9.58 and a 52 week high of $18.50. The stock’s fifty day moving average is $14.43 and its two-hundred day moving average is $15.46. The company has a market capitalization of $457.32 million, a P/E ratio of -278.94, a P/E/G ratio of 3.32 and a beta of 0.38.

Cross Country Healthcare (NASDAQ:CCRN) last posted its earnings results on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. Cross Country Healthcare’s quarterly revenue was down 22.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 EPS. Sell-side analysts anticipate that Cross Country Healthcare will post 0.53 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cross Country Healthcare

Hedge funds have recently added to or reduced their stakes in the business. Quadrant Capital Group LLC purchased a new stake in shares of Cross Country Healthcare during the fourth quarter worth $25,000. Plato Investment Management Ltd purchased a new position in Cross Country Healthcare in the fourth quarter valued at approximately $46,000. Longfellow Investment Management Co. LLC acquired a new stake in Cross Country Healthcare during the first quarter worth approximately $59,000. AlphaQuest LLC lifted its position in shares of Cross Country Healthcare by 324.6% during the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider’s stock worth $124,000 after buying an additional 6,343 shares during the last quarter. Finally, Mint Tower Capital Management B.V. acquired a new position in shares of Cross Country Healthcare in the 4th quarter valued at $182,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.